khk4083
mAbexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02647866)
Timeline
Indications
Studied for
Mechanism of action
TNFSF4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- khk4083
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03703102 | Phase 2 | Oct 22, 2018 | Kyowa Hakko Kirin, Kyowa Kirin |
| NCT03096223 | Phase 1 | May 1, 2017 | Kyowa Hakko Kirin |
| NCT02985593 | Phase 1 | Dec 1, 2016 | Kyowa Hakko Kirin |
| NCT02647866 | Phase 2 | Dec 1, 2015 | Kyowa Hakko Kirin |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kyowa Hakko Kirin | For profit | 4 | 3 | 2 | 2015 |
| Kyowa Kirin | For profit | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1